tiprankstipranks
Advertisement
Advertisement

VRTX Stock Latest News

Vertex’s VX-581 Dose Escalation Trial: A Fresh Signal on Cystic Fibrosis Pipeline Strength
Company AnnouncementsVertex’s VX-581 Dose Escalation Trial: A Fresh Signal on Cystic Fibrosis Pipeline Strength
6d ago
VRTX
After Crinetics’ $10 Billion Deal, Could Entera Bio Be the Next Category-Defining Oral Peptide Story?
PremiumTipRanks Newswire
After Crinetics’ $10 Billion Deal, Could Entera Bio Be the Next Category-Defining Oral Peptide Story?
7d ago
AZN
LLY
Vertex Pharmaceuticals price target raised to $585 from $545 at UBS
PremiumThe Fly
Vertex Pharmaceuticals price target raised to $585 from $545 at UBS
9d ago
VRTX
Vertex Pharmaceuticals price target raised to $560 from $542 at Truist
PremiumThe Fly
Vertex Pharmaceuticals price target raised to $560 from $542 at Truist
9d ago
VRTX
Vertex Pharmaceuticals price target raised to $600 from $598 at BofA
PremiumThe Fly
Vertex Pharmaceuticals price target raised to $600 from $598 at BofA
9d ago
VRTX
Vertex Pharmaceuticals: Buy Rating Reaffirmed as Analyst Lifts Price Target from $598 to $600 on Robust CF Growth and Emerging Nephrology/Endocrinology Upside
PremiumRatingsVertex Pharmaceuticals: Buy Rating Reaffirmed as Analyst Lifts Price Target from $598 to $600 on Robust CF Growth and Emerging Nephrology/Endocrinology Upside
9d ago
VRTX
3 Trending Stocks to Watch, According to Analysts – 7/9/2026
Premium
Market News
3 Trending Stocks to Watch, According to Analysts – 7/9/2026
12d ago
XOM
CRNX
Vertex: Buy Rating Reaffirmed as Crinetics Deal Broadens Revenue Base; $575 Price Target Maintained
Premium
Ratings
Vertex: Buy Rating Reaffirmed as Crinetics Deal Broadens Revenue Base; $575 Price Target Maintained
12d ago
VRTX
The Billion-Dollar Pill: With NXP100, Nuvectis Pharma Just Staked Its Claim in the New Biotech Gold Rush
PremiumTipRanks Newswire
The Billion-Dollar Pill: With NXP100, Nuvectis Pharma Just Staked Its Claim in the New Biotech Gold Rush
13d ago
LLY
ABBV
Crinetics downgraded to Hold from Buy at TD Cowen
PremiumThe Fly
Crinetics downgraded to Hold from Buy at TD Cowen
14d ago
CRNX
VRTX
Midday Fly By: Wall Street starts coverage of SpaceX with bullish ratings
PremiumThe Fly
Midday Fly By: Wall Street starts coverage of SpaceX with bullish ratings
15d ago
AAL
LMT
Wedbush sees BioCryst, Ascendis as potential next targets after Crinetics deal
PremiumThe Fly
Wedbush sees BioCryst, Ascendis as potential next targets after Crinetics deal
15d ago
ASND
BCRX
Morning Movers: Lam Research and Micron dip after Samsung quarterly results
PremiumThe FlyMorning Movers: Lam Research and Micron dip after Samsung quarterly results
15d ago
MU
Vertex–Crinetics Deal Broadens Endocrinology Portfolio but Integration Uncertainties and Valuation Keep Rating at Hold, Price Target Unchanged at $436
Premium
Ratings
Vertex–Crinetics Deal Broadens Endocrinology Portfolio but Integration Uncertainties and Valuation Keep Rating at Hold, Price Target Unchanged at $436
15d ago
VRTX
Vertex adds ‘genuine fifth commercial pillar’ with deal, says H.C. Wainwright
Premium
The Fly
Vertex adds ‘genuine fifth commercial pillar’ with deal, says H.C. Wainwright
15d ago
CRNX
VRTX
Vertex Pharmaceuticals price target raised to $570 from $543 at RBC Capital
PremiumThe Fly
Vertex Pharmaceuticals price target raised to $570 from $543 at RBC Capital
15d ago
VRTX
Vertex Pharmaceuticals price target raised to $350 from $330 at Baird
PremiumThe Fly
Vertex Pharmaceuticals price target raised to $350 from $330 at Baird
15d ago
VRTX
Crinetics price target raised to $85 from $62 at Baird
PremiumThe Fly
Crinetics price target raised to $85 from $62 at Baird
15d ago
CRNX
VRTX
Vertex Pharmaceuticals to Acquire Crinetics in Cash Merger
PremiumCompany Announcements
Vertex Pharmaceuticals to Acquire Crinetics in Cash Merger
15d ago
8K
VRTX
Crinetics downgraded to Perform from Outperform at Oppenheimer
PremiumThe FlyCrinetics downgraded to Perform from Outperform at Oppenheimer
15d ago
CRNX
VRTX
Why Is Crinetics Stock (CRNX) Surging Nearly 100% in Pre-Market Today, 7/7/26? Analysts React
Premium
Market News
Why Is Crinetics Stock (CRNX) Surging Nearly 100% in Pre-Market Today, 7/7/26? Analysts React
15d ago
CRNX
VRTX
Vertex’s $10 Billion Crinetics Acquisition Adds Endocrinology Growth Pillars, Supporting Long-Term Buy Thesis
Premium
Ratings
Vertex’s $10 Billion Crinetics Acquisition Adds Endocrinology Growth Pillars, Supporting Long-Term Buy Thesis
15d ago
VRTX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >